Empagliflozin (BI 10773) Comprehensive add-on Study in Japanese Subjects With Type 2 Diabetes Mellitus

NCT01368081 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1162

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Metformin
DRUG: BI 10773
DRUG: Placebo (low dose)
DRUG: BI 10773
DRUG: Placebo (high dose)

Sponsor

Boehringer Ingelheim

Collaborators

[object Object]